Assignment Help

Write 6 pages thesis on the topic pharmaceutical industry in the global economy. The BMS foundation is to encourage universal health equity by mobilizing communities to fight diseases.

The Bristol-Myers Squibb went through an incredibly planned change. It has acquired important new companies and spinning off others. It has developed into a major pharmaceutical company (Pearce & Robinson, 2015). When the company hired the CEO James Cornelius a strategy called the “string of pearls” was formed. The strategy focused on Bristol restocking its product pipeline by acquiring small and medium-sized businesses that had promising products in development. Bristol has gone beyond its core disease areas to new formulations like the fibrosis and congestive heart failure for deal-making. It entered into strategic alliance agreements with Pfizer and AstraZeneca to co-commercialize and co-develop investigational compounds. The agreements with AstraZeneca involved the compounds that are used to treat diabetes while that of the Pfizer focused on anticoagulant that was used for the treatment and prevention of venous and arterial thrombotic conditions (Bristol-Myers Squibb, 2014).

The Bristol Company purchased Kosan Biosciences, a company that is cancer therapeutic, which provided the classes of anticancer agents in 2008. It also acquired a Medarex in 2009 which expanded the company’s oncology pipeline and gave it full rights to immunotherapy that studied prostate cancer, lung cancer, and melanoma (Pearce & Robinson, 2015). In 2010, the company purchased ZymoGenetics which gave it the full rights to investigate compounds for the hepatitis-C virus and it was the first time it secured an existing product called Recothrom that was used to control bleeding during surgery.&nbsp.In 2011, Bristol acquired Amira and Ambrx Pharmaceuticals Inc. The Amira developed pharmaceuticals for fibrosis hence complementing the company’s therapeutic research efforts while the Ambrx produced drugs for diabetes and congestive heart failure.